intrinsic-factor and Prostatic-Neoplasms

Induction of apoptotic cell death mechanism can be regulated by internal factor(s), such as by gene product(s) that directly upregulate the apoptosis pathway or indirectly by down-regulating the anti-apoptosis gene. This homeostasis is a normal phenomenon in a biological system disturbed by cancer. It is thus important to find any gene functioning as an upregulator for the apoptosis pathway that may have a potential application in the context of cancer gene therapy. We have cloned a novel rat gene, denoted as pHyde, that fulfilled this objective. Internally, this pHyde gene product renders the stable transfectant of rat prostatic cancer cell lines more susceptible to apoptosis even without any external inducer. By using an external agent, such as 5-fluoro-2'-deoxyuridine (FdUr), apoptotic responses of the stable transfectants are even higher, suggesting that both intrinsic and extrinsic factors work synergistically. The pHyde gene product was termed an intrinsic factor, whereas FdUr was considered an extrinsic factor for the apoptosis in rat prostate cancer model.

Topics: Animals; Apoptosis; Cell Cycle; DNA Damage; DNA Repair; Fluorodeoxyuridylate; Gene Expression Regulation, Neoplastic; Humans; Intrinsic Factor; Male; Prostatic Neoplasms; Rats; Tumor Cells, Cultured

It has been estimated that there will be > 180,400 new cases of prostate cancer and 31,900 prostate cancer deaths in the United States this year. New therapeutic strategies against locally advanced prostate cancer are desperately needed. A novel gene (pHyde) was identified by an improved cDNA competition hybridization technique for Dunning rat prostate cancer cell lines. A recombinant replication-deficient E1/E3-deleted adenovirus type 5 containing a pHyde gene under the control of a truncated Rous sarcoma virus (RSV) promoter (AdRSVpHyde) was generated. In vitro, AdRSVpHyde significantly inhibited growth of human prostate cancer cell lines DU145 and LNCaP in culture. In vivo, a single injection of AdRSVpHyde (5 x 10(9) plaque-forming units) reduced DU145 tumors in nude mice remarkably compared with untreated control or viral control-treated DU145 tumors. Moreover, AdRSVpHyde induced apoptosis and stimulated p53 expression. These results together suggest that pHyde is a tumor suppressor gene that inhibits growth of prostate cancer and that this inhibition is at least in part due to the induction of apoptosis.

Topics: Adenovirus E1 Proteins; Adenovirus E3 Proteins; Adenoviruses, Human; Amino Acid Sequence; Animals; Apoptosis; Avian Leukosis Virus; DNA, Complementary; Genes, Tumor Suppressor; Genetic Therapy; Growth Inhibitors; Humans; Intrinsic Factor; Male; Mice; Mice, Nude; Molecular Sequence Data; Promoter Regions, Genetic; Prostatic Neoplasms; Rats; Tumor Cells, Cultured; Tumor Suppressor Protein p53